Costa Bachas, PhD, Amsterdam University Medical Center, Amsterdam, Netherlands, comments on the challenges of implementing computational measurable residual disease (MRD) assessment in clinical practice. He highlights the need for thorough validations of algorithms to comply with regulatory requirements and medical equipment regulations. Dr Bachas emphasizes the importance of explainable statistical modeling to ensure reliable and interpretable results, particularly in stratifying therapy decisions for patients. This interview took place at the 19th International Symposium on Acute Leukemias (ISAL XIX) in Munich, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Watch video Implementing computational MRD assessment into clinical practice: challenges and solutions online without registration, duration hours minute second in high quality. This video was added by user VJHemOnc – Video Journal of Hematology & HemOnc 14 April 2025, don't forget to share it with your friends and acquaintances, it has been viewed on our site 54 once and liked it 1 people.